Thermo Fisher Scientific and University of California, San Francisco to Open Cell Therapy cGMP Manufacturing and Collaboration Center Read more
GSK and Vir Biotechnology announce EMA review of dual-action monoclonal antibody VIR-7831 for the early treatment of COVID-19 Read more
FDA Grants Accelerated Approval to Trodelvy for the Treatment of Metastatic Urothelial Cancer Read more
AstraZeneca to supply the US with up to half a million additional doses of the potential COVID-19 antibody treatment AZD7442 Read more
Novartis ligelizumab (QGE031) receives FDA Breakthrough Therapy designation for patients with chronic spontaneous urticaria (CSU) Read more